CLU and Cognitive impairment: Studies measuring protein levels in cerebrospinal fluid (CSF) revealed elevated CSF clusterin in AD cases compared with controls [10], and a study of non‐demented and mild cognitive impairment patients revealed increased CSF clusterin was related to amyloid β‐associated brain atrophy [11].